Microsatellite stable rectal carcinoma
Clinical trials for Microsatellite stable rectal carcinoma explained in plain language.
Never miss a new study
Get alerted when new Microsatellite stable rectal carcinoma trials appear
Sign up with your email to follow new studies for Microsatellite stable rectal carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can two immunotherapy drugs eliminate early rectal cancer without surgery?
Cure Recruiting nowThis phase 2 trial is testing whether a combination of two immunotherapy drugs, botensilimab and balstilimab, can completely eliminate early-stage rectal cancer in people whose tumors are microsatellite stable (MSS). Participants receive one infusion of botensilimab followed by b…
Matched conditions: MICROSATELLITE STABLE RECTAL CARCINOMA
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Cure
Last updated Aug 20, 2026 00:00 UTC
-
Immunotherapy duo takes on tough rectal cancer
Disease control Recruiting nowThis study tests whether two immunotherapy drugs, botensilimab and balstilimab, can shrink or eliminate rectal tumors in people with a specific type of rectal cancer (MMRp/MSS) that usually doesn't respond to immunotherapy alone. About 40 adults with stage II or III rectal cancer…
Matched conditions: MICROSATELLITE STABLE RECTAL CARCINOMA
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC